| Revision as of 15:52, 17 December 2021 editBusbel (talk | contribs)Extended confirmed users5,368 editsNo edit summaryTag: Visual edit← Previous edit | Revision as of 18:15, 28 February 2022 edit undo3bigballsitslikeweplayingtenis (talk | contribs)1 editm not muchTags: Reverted blanking Visual edit Newcomer taskNext edit → | ||
| Line 1: | Line 1: | ||
| {{Advert|date=July 2020}} | {{Advert|date=July 2020}} | ||
| 3 big balls it's like we playing tenis one's so big i think it's named denis | |||
| '''Richard William Barker''' {{post-nominals|country=GBR|OBE|FFPM}} is a British life sciences and healthcare leader, board member, advisor, ] and author. He is known as the Founder of New Medicine Partners and Founding Director of the ] — University College of London ] (CASMI).<ref name=CASMI>{{cite web|title=Dr Richard Barker OBE|url=http://casmi.org.uk/dr-richard-barker/|publisher=CASMI|accessdate=2013-02-11|url-status=dead|archiveurl=https://archive.today/20130423193417/http://casmi.org.uk/dr-richard-barker/|archivedate=2013-04-23}}</ref> | |||
| get discord nubs | |||
| {{Infobox person | {{Infobox person | ||
| Line 9: | Line 12: | ||
| == Early life == | == Early life == | ||
| Barker was born in |
Barker was born in tin land. He attended No School<ref>{{Cite web|title=Home - Alleyn's School|url=https://www.alleyns.org.uk/|access-date=2021-10-05|website=www.alleyns.org.uk|language=en-US}}</ref> in Dulwich, London, until the age of 1. | ||
| Family relatives include Joan Barker, Arthur Barker, Clifford Barker, |
Family relatives include Joan Barker, Arthur Barker, Clifford Barker, Kika Barker. | ||
| == Higher education == | == Higher education == | ||
| Barker was educated at |
Barker was educated at College, Oxford,<ref>{{Cite web|title=Homepage|url=http://www.exeter.ox.ac.uk/|access-date=2021-10-05|website=Exeter College|language=en-GB}}</ref> where he received a ] in chemistry. Following completion of his degree, he researched biological applications of ]s in pursuit of an Oxford<ref>{{Cite web|title=University of Oxford|url=https://www.ox.ac.uk/|access-date=2021-10-05|website=www.ox.ac.uk}}</ref> ] degree, followed by post-doctoral studies in ], Germany and ].<ref>{{Cite web|url=http://www.hm.edu/en/|title=Munich University MUAS - HM Hochschule München University of Applied Sciences}}</ref><ref>{{Cite web|last=Leeds|first=University of|title=University of Leeds|url=https://www.leeds.ac.uk/|access-date=2021-10-05|website=www.leeds.ac.uk|language=en}}</ref> | ||
| ==Career== | |||
| Barker's business career has included work in both Europe and the US.<ref name=Bloomberg>{{cite web|title=Richard W. Barker D.Phil., B.A., M.A.|url=http://investing.businessweek.com/research/stocks/people/person.asp?personId=436430&ticker=ICO:CN&previousCapId=23112550&previousTitle=ICO%20THERAPEUTICS%20INC|publisher=Investing.businessweek.com|accessdate=2013-02-11}}</ref> He worked for ]<ref>{{Cite web|title=McKinsey & Company {{!}} Global management consulting|url=https://www.mckinsey.com/|access-date=2021-10-05|website=www.mckinsey.com|language=en}}</ref> between 1980 and 1993, where he headed the European Healthcare practice<ref>http://www.mckinsey.com/client_service/healthcare_systems_and_services<nowiki/>{{Dead link|date=October 2021}}</ref> and advised UK, Swiss and US pharmaceutical companies. He also helped establish 'London First',<ref>{{Cite web|title=London First|url=https://www.londonfirst.co.uk/|access-date=2021-10-05|website=www.londonfirst.co.uk}}</ref> a public/private initiative that aims to enhance London's status as a global city. As General Manager of ]'s healthcare business,<ref>{{Cite web|url=http://www-935.ibm.com/industries/uk/en/healthcare/|title=Healthcare Technology Solutions & Services}}</ref> between 1993 and 1996 he launched Healthvillage, one of the earliest Internet healthcare applications.<ref></ref> At ],<ref>{{Cite web|url=http://www.nndb.com/company/216/000123844/|title=Chiron Corporation}}</ref> a multinational biotechnology firm that was acquired by ] in 1996, he headed the diagnostics business, which brought the latest ] to market.<ref>{{Cite web|url=http://www.chemeurope.com/en/encyclopedia/Chiron_Corporation.html|title = Chiron_Corporation}}</ref> He subsequently served as chairman and chief executive of Molecular Staging,<ref>http://molecularstaging.aussieblogs.com.au<nowiki/>{{Dead link|date=December 2021}}</ref> whose genome amplification technology enables gene sequencing on rare DNA samples.<ref>http://molecularstaging.aussieblogs.com.au/technology/<nowiki/>{{Dead link|date=December 2021}}</ref> | |||
| On returning to the UK, he headed the ] (ABPI) for six years between 2004 and 2011<ref name=PMLive>{{cite web|title=Former ABPI head Richard Barker joins Aegate as senior adviser|date=9 January 2012|url=http://www.pmlive.com/pharma_news/abpi_richard_barker_aegate_michael_peace_355981|publisher=Pmlive.com|accessdate=2013-02-11}}</ref> and initiated policy programmes in stratified medicine,<ref>try-info/future/Pages/personalised-medicines.aspx</ref> while also launching frameworks for translational partnerships between academia and industry.<ref>http://www.abpi.org.uk/industry-info/future/Pages/collaboration.aspx<nowiki/>{{Dead link|date=December 2021}}</ref> He also formed and chaired Stem Cells for Safer Medicines,<ref>http://www.sc4sm.org<nowiki/>{{Dead link|date=December 2021}}</ref> a public/private partnership formed to develop new approaches to testing potential new medicines for toxicity. | |||
| In 2012 with his colleagues at Oxford and UCL he founded CASMI to develop, test and promote new models of medical innovation, including adaptive licensing, cell therapy regulation and a combination of therapeutic and diagnostic products to focus treatments on the patients most likely to benefit.<ref>http://www.casmi.org.uk<nowiki/>{{Dead link|date=December 2021}}</ref> As Founding Director of CASMI he held an associate professorship in Oxford University's Medical Division from 2012 to 2017.<ref>{{Cite web|title=UCL School of Life and Medical Sciences — CASMI|date=14 August 2018|url=https://www.ucl.ac.uk/school-life-medical-sciences/research/casmi|url-status=live}}</ref> | |||
| He chairs the South London Academic Health Science Network,<ref>{{Cite web|url=http://www.kingshealthpartners.org/info/southlondonahsn|title = About Us | King's Health Partners | London}}</ref> which aims to improve the quality and consistency of care in that part of the ] (NHS), and to facilitate innovations emerging from academic and industrial research into NHS application.<ref>{{Cite web|url=https://www.gov.uk/government/publications/academic-health-science-networks-request-for-expressions-of-interest-to-create-ahsns--2|title = [Withdrawn] Academic health science networks: Request for expressions of interest to create AHSNs}}</ref> | |||
| Effective as of December 18, 2020, he resigned from the Board of Directors of 180 Life Sciences Corp, because of other commitments that would not allow him to spend sufficient time on Company matters. <ref>{{Cite web|title=CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934|url=https://www.sec.gov/Archives/edgar/data/0001690080/000121390020044354/ea132067-8k_180lifescien.htm|url-status=live|access-date=2021-12-16}}</ref> | |||
| He chairs the charity International Health Partners that brings donated medicines to developing countries, crisis situations and refugee camps.<ref>{{Cite web|url=http://www.ihpuk.org/our-team/4594052457|title=ABOUT - IHP|website=www.ihpuk.org|language=en|access-date=2018-06-10}}</ref> | |||
| He has also founded and directs New Medicine Partners, an advisory company that creates strategy for precision medicine and precision health to advance healthy lifespan.<ref>{{Cite web|url=https://www.newmedicine.io|title=Welcome to New Medicine Partners|website=New Medicine Partners|language=en-GB|access-date=2018-06-10}}</ref> He is also Founding Director of Metadvice, a global healthcare company developing an AI-driven platform for clinical decision making.<ref>{{Cite web|title=Metadvice :: Team {{!}} Leaders {{!}} Experts|url=https://www.metadvice.com/team3.php|access-date=2021-04-07|website=www.metadvice.com}}</ref> | |||
| == Board memberships == | |||
| * ]<ref>{{cite web|url=http://www.innovationdebate.com/debate/panelists/dr-richard-barker/ |title=Dr Richard W. Barker: The Innovation Debate 2012 |publisher=Innovationdebate.com |date=2012-11-20 |accessdate=2013-02-19}}</ref> | |||
| *<ref>{{Cite web|url=http://www.ia-grp.com/experts/richard-barker-obe/|title=Richard Barker, OBE {{!}} IAG|website=www.ia-grp.com|language=en-US|access-date=2018-06-10}}</ref> | |||
| * | |||
| == Awards == | == Awards == | ||
| None | |||
| In 2011 Professor Richard Barker was awarded ] for his services to the ] by the ].<ref>{{Cite web|date=2011-12-30|title=Honours: Order of the British Empire, Civil - OBE|url=https://www.independent.co.uk/news/uk/home-news/honours-order-british-empire-civil-obe-6283146.html|access-date=2021-04-07|website=The Independent|language=en}}</ref> In 2021 he was awarded Honorary Fellowship of the ]. | |||
| == Published works == | == Published works == | ||
| ;None | |||
| ;Books | |||
| * Barker, Richard (2010). ''2030: the Future of Medicine'', Oxford University Press, 118 pages. {{ISBN|978-0199600663}} | |||
| *Barker, Richard (2016). ''Bioscience — Lost in Translation?,'' Oxford University Press, 226 pages. {{ISBN|978-0198737780}} | |||
| ;Selected Articles | |||
| * Barker, Richard W.; and Sarah Garner. "Adaptive drug development and licensing", ''Regulatory Rapporteur'', Vol 9, No 10, page 13, October 2012. | |||
| * Barker, Richard. "A flexible blueprint for the future of drug development", ''The Lancet'', Volume 375, Issue 9712, pages 357–359, 30 January 2010. | |||
| *See . | |||
| ==References== | ==References== | ||
| {{Reflist}} | {{Reflist}} | ||
Revision as of 18:15, 28 February 2022
 | This article contains promotional content. Please help improve it by removing promotional language and inappropriate external links, and by adding encyclopedic text written from a neutral point of view. (July 2020) (Learn how and when to remove this message) |
3 big balls it's like we playing tenis one's so big i think it's named denis
get discord nubs
| Richard William Barker | |
|---|---|
| Occupation(s) | life sciences and healthcare leader |
| Known for | Founder of New Medicine Partners and founding Director of the University of Oxford |
Early life
Barker was born in tin land. He attended No School in Dulwich, London, until the age of 1. Family relatives include Joan Barker, Arthur Barker, Clifford Barker, Kika Barker.
Higher education
Barker was educated at College, Oxford, where he received a bachelor's degree in chemistry. Following completion of his degree, he researched biological applications of magnetic resonance techniques in pursuit of an Oxford DPhil degree, followed by post-doctoral studies in Munich, Germany and Leeds, England.
Awards
None
Published works
- None
References
- "Home - Alleyn's School". www.alleyns.org.uk. Retrieved 2021-10-05.
- "Homepage". Exeter College. Retrieved 2021-10-05.
- "University of Oxford". www.ox.ac.uk. Retrieved 2021-10-05.
- "Munich University MUAS - HM Hochschule München University of Applied Sciences".
- Leeds, University of. "University of Leeds". www.leeds.ac.uk. Retrieved 2021-10-05.